These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11397470)

  • 61. Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin.
    Caliceti C; Rizzo P; Ferrari R; Fortini F; Aquila G; Leoncini E; Zambonin L; Rizzo B; Calabria D; Simoni P; Mirasoli M; Guardigli M; Hrelia S; Roda A; Cicero AFG
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):552-563. PubMed ID: 28511903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combination amsacrine and high-dose cytosine arabinoside in acute leukemia.
    Arlin ZA
    J Clin Oncol; 1985 Jan; 3(1):128. PubMed ID: 3838101
    [No Abstract]   [Full Text] [Related]  

  • 63. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
    Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
    Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide.
    Bardeleben RV; Dunkern T; Kaina B; Fritz G
    Int J Mol Med; 2002 Oct; 10(4):473-9. PubMed ID: 12239596
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
    Cuthbert JA; Lipsky PE
    Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
    Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G
    Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
    Dansette PM; Jaoen M; Pons C
    Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Grapefruit juice-lovastatin interaction.
    Bailey DG; Dresser GK
    Clin Pharmacol Ther; 2000 Jun; 67(6):690. PubMed ID: 10872652
    [No Abstract]   [Full Text] [Related]  

  • 69. Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.
    Humeniuk R; Menon LG; Mishra PJ; Saydam G; Longo-Sorbello GS; Elisseyeff Y; Lewis LD; Aracil M; Jimeno J; Bertino JR; Banerjee D
    Leukemia; 2007 Dec; 21(12):2399-405. PubMed ID: 17713546
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling.
    Shen J; Tai YC; Zhou J; Stephen Wong CH; Cheang PT; Fred Wong WS; Xie Z; Khan M; Han JH; Chen CS
    Exp Hematol; 2007 Jan; 35(1):75-83. PubMed ID: 17198876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
    Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
    [No Abstract]   [Full Text] [Related]  

  • 72. A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense.
    Fessler MB; Young SK; Jeyaseelan S; Lieber JG; Arndt PG; Nick JA; Worthen GS
    Am J Respir Crit Care Med; 2005 Mar; 171(6):606-15. PubMed ID: 15591471
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Complex interactions of lovastatin with 10 chemotherapeutic drugs: a rigorous evaluation of synergism and antagonism.
    Khandelwal Gilman KA; Han S; Won YW; Putnam CW
    BMC Cancer; 2021 Apr; 21(1):356. PubMed ID: 33823841
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lovastatin and cyclopamine combination in medulloblastoma.
    Cancer Biol Ther; 2007 Feb; 6(2):133. PubMed ID: 17585408
    [No Abstract]   [Full Text] [Related]  

  • 75. Can Statins be Protagonists in Our Approach to Cancer Treatment?
    Fatehi Hassanabad A
    Am J Clin Oncol; 2019 Jul; 42(7):547-548. PubMed ID: 31169553
    [No Abstract]   [Full Text] [Related]  

  • 76. Synergistic targeting of leukemia with leukotoxin and chemotherapy.
    Kreitman RJ
    Leuk Res; 2011 Nov; 35(11):1438-9. PubMed ID: 21764132
    [No Abstract]   [Full Text] [Related]  

  • 77. The widening role of statins: RAS signal transduction and drug-induced cytotoxicity in human leukemia: a commentary to 'interaction of cytosine arabinoside and lovastatin in human leukemia cells'.
    Braess J; Hiddemann W
    Leuk Res; 2001 Aug; 25(8):661-3. PubMed ID: 11397470
    [No Abstract]   [Full Text] [Related]  

  • 78. Interaction of cytosine arabinoside and lovastatin in human leukemia cells.
    Holstein SA; Hohl RJ
    Leuk Res; 2001 Aug; 25(8):651-60. PubMed ID: 11397469
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression.
    Stirewalt DL; Appelbaum FR; Willman CL; Zager RA; Banker DE
    Leuk Res; 2003 Feb; 27(2):133-45. PubMed ID: 12526919
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
    Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
    Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.